Intensity Therapeutics, Inc.

NasdaqCM:INTS Stock Report

Market Cap: US$43.4m

Intensity Therapeutics Balance Sheet Health

Financial Health criteria checks 4/6

Intensity Therapeutics has a total shareholder equity of $2.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.2M and $2.4M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$2.78m
EquityUS$2.78m
Total liabilitiesUS$2.43m
Total assetsUS$5.21m

Recent financial health updates

We're Not Very Worried About Intensity Therapeutics' (NASDAQ:INTS) Cash Burn Rate

Apr 16
We're Not Very Worried About Intensity Therapeutics' (NASDAQ:INTS) Cash Burn Rate

We're Hopeful That Intensity Therapeutics (NASDAQ:INTS) Will Use Its Cash Wisely

Dec 29
We're Hopeful That Intensity Therapeutics (NASDAQ:INTS) Will Use Its Cash Wisely

Recent updates

We're Not Very Worried About Intensity Therapeutics' (NASDAQ:INTS) Cash Burn Rate

Apr 16
We're Not Very Worried About Intensity Therapeutics' (NASDAQ:INTS) Cash Burn Rate

We're Hopeful That Intensity Therapeutics (NASDAQ:INTS) Will Use Its Cash Wisely

Dec 29
We're Hopeful That Intensity Therapeutics (NASDAQ:INTS) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: INTS's short term assets ($3.8M) exceed its short term liabilities ($2.3M).

Long Term Liabilities: INTS's short term assets ($3.8M) exceed its long term liabilities ($117.0K).


Debt to Equity History and Analysis

Debt Level: INTS is debt free.

Reducing Debt: INTS had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: INTS has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: INTS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.8% each year


Discover healthy companies